Israel Influenza B Market (2025-2031) | Industry, Restraints, Value, Share, Supply, Competitive, Outlook, Competition, Demand, Drivers, Companies, Analysis, Strategy, Opportunities, Forecast, Growth, Segments, Strategic Insights, Pricing Analysis, Investment Trends, Segmentation, Trends, Revenue, Consumer Insights, Size, Challenges

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Influenza B Market Revenues & Volume, 2021 & 2031F

3.3 Israel Influenza B Market - Industry Life Cycle

3.4 Israel Influenza B Market - Porter's Five Forces

3.5 Israel Influenza B Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 Israel Influenza B Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 Israel Influenza B Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F

3.8 Israel Influenza B Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about the importance of influenza vaccination in Israel

4.2.2 Growing elderly population in Israel, who are more susceptible to influenza B

4.2.3 Government initiatives to promote influenza vaccination and reduce the disease burden

4.3 Market Restraints

4.3.1 Seasonal nature of influenza outbreaks leading to fluctuating demand for vaccines

4.3.2 Competition from alternative preventive measures or treatments for influenza B

4.3.3 Limited access to healthcare services in certain regions of Israel

6.1 Israel Influenza B Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 Israel Influenza B Market Revenues & Volume, By Drug Type, 2021 - 2031F

6.1.3 Israel Influenza B Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Baloxavir), 2021 - 2031F

6.1.4 Israel Influenza B Market Revenues & Volume, By Symptom Management (Pain Relievers, Antihistamines), 2021 - 2031F

6.2 Israel Influenza B Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 Israel Influenza B Market Revenues & Volume, By Oral, 2021 - 2031F

6.2.3 Israel Influenza B Market Revenues & Volume, By Intravenous, 2021 - 2031F

6.2.4 Israel Influenza B Market Revenues & Volume, By Inhalation, 2021 - 2031F

6.3 Israel Influenza B Market, By Patient Age Group

6.3.1 Overview and Analysis

6.3.2 Israel Influenza B Market Revenues & Volume, By Pediatric, 2021 - 2031F

6.3.3 Israel Influenza B Market Revenues & Volume, By Adult, 2021 - 2031F

6.3.4 Israel Influenza B Market Revenues & Volume, By Geriatric, 2021 - 2031F

6.4 Israel Influenza B Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 Israel Influenza B Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F

6.4.3 Israel Influenza B Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F

6.4.4 Israel Influenza B Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F

7.1 Israel Influenza B Market Export to Major Countries

7.2 Israel Influenza B Market Imports from Major Countries

8.1 Percentage increase in influenza vaccination coverage rates in Israel

8.2 Number of reported influenza B cases in high-risk populations (e.g., elderly, children)

8.3 Rate of adoption of new and improved influenza B vaccines in the market

9.1 Israel Influenza B Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 Israel Influenza B Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 Israel Influenza B Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F

9.4 Israel Influenza B Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Israel Influenza B Market Revenue Share, By Companies, 2024

10.2 Israel Influenza B Market Competitive Benchmarking, By Operating and Technical Parameters